Oxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation
|
|
- Joel Farmer
- 5 years ago
- Views:
Transcription
1 J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue Oxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation Jeff C. H. Ko, DVM, MS, DACVA a Ann B. Weil, DVM, MS, DACVA a Takashi Kitao, DVM b Mark E. Payton, PhD c Tomohito Inoue, DVM a a Department of Veterinary Clinical Sciences School of Veterinary Medicine Purdue University West Lafayette, IN b Center for Veterinary Health Sciences c Department of Statistics College of Arts and Sciences Oklahoma State University Stillwater, OK CLINICAL RELEVANCE Oxygenation status was evaluated in medetomidine-sedated dogs breathing room air (M) or 100% oxygen (MO 2 ). Medetomidine (40 µg/kg IV) administration resulted in peripheral vasoconstriction and decreased venous saturation as measured by an increased oxygen extraction ratio in peripheral tissues. Providing 100% oxygen insufflation via face mask reduced desaturation by increasing oxygen content but did not prevent vasoconstriction or reduce the oxygen extraction ratio in peripheral tissues. Atipamezole (200 µg/kg IV) reversed medetomidine-induced vasoconstriction and increased oxygen supply to tissues as indicated by a lower tissue oxygen extraction ratio. The authors conclude that 100% oxygen insufflation via face mask during medetomidine sedation (40 µg/kg IV) benefits tissue oxygenation in healthy dogs. INTRODUCTION Medetomidine or sedative analgesic combinations incorporating medetomidine are commonly used by practitioners to sedate dogs. 1 Clinically useful doses of medetomidine range from 10 to 80 µg/kg. 2 In dogs sedated with medetomidine alone or in combination, a cyanotic tongue and pale mucous membranes are often observed, and this is considered a worrisome side effect. 1,3 5 The mechanisms of peripheral tissue blood desaturation induced by medetomidine are not clearly understood. The bluish to pale mucous membrane color is thought to be due to peripheral vasoconstriction resulting in slower blood flow through peripheral capillary beds and increased tissue extraction of oxygen causing increased venous desaturation. 1,3,4 Because dogs sedated with medetomidine or other α 2 agonists frequently recover normally when breathing room air, controversy exists as to whether 100% oxygen supplementation should be provided. 51
2 Veterinary Therapeutics Vol. 8, No. 1, Spring 2007 mals. Lactate concentration in the blood is a measure of anaerobic cellular metabolism, which occurs when cells are not receiving adequate levels of oxygen to support normal aerobic metabolism. 11 Lactate values can also be used to guide therapy. Once oxygen therapy is instituted, lactate concentration often decreases with restoration of aerobic metabolism. 11 We were unable to find reports comparing blood lactate concentrations in medetomidine-sedated dogs breathing room air versus 100% oxygen. Because dogs sedated with medetomidine or other α 2 agonists frequently recover normally when breathing room air, controversy exists as to whether 100% oxygen supplementation should be provided. The total amount of oxygen carried in the arterial and venous blood is usually expressed as oxygen content for arterial (CaO 2 ) and mixed venous (CvO 2 ) blood. 6 CaO 2 and CvO 2 are influenced by the amount of hemoglobin available to bind oxygen, or hemoglobin saturation for oxygen (SaO 2 [arterial] or SvO 2 [venous]), and the amount of oxygen dissolved in the blood, or partial pressure of oxygen (PaO 2 [arterial] or PvO 2 [venous]). Studies have measured oxygen saturation and partial pressure of oxygen in medetomidine-sedated dogs breathing room air or 100% oxygen. 7,8 Clinical impressions are that venous blood samples are darker in color after sedation with medetomidine, potentially indicating lower blood oxygen content. The oxygen content difference between arterial and mixed venous blood (CaO 2 CvO 2 ) can help quantify oxygen extraction by the tissues. 9,10 The most common site for collecting samples of mixed venous blood for determining oxygen extraction ratio is from a catheter placed in the pulmonary artery. However, to our knowledge, there is no information available concerning the measurement of oxygen content from arterial and peripheral venous samples over time in medetomidine-sedated dogs. Furthermore, a direct comparison of oxygen content from arterial and peripheral venous samples in medetomidine-sedated dogs breathing room air versus those receiving 100% oxygen insufflation has not been performed. Measurement of blood lactate has been indirectly correlated with tissue oxygenation in ani- Atipamezole is a highly specific antagonist for α 2 -adrenergic agents such as medetomidine. The effect of atipamezole on CaO 2, CvO 2, and CaO 2 CvO 2, as well as lactate concentration immediately following reversal of medetomidine, has not been well documented. The purposes of this study were (1) to determine whether there was a decrease in CaO 2 and CvO 2 from peripheral blood following medetomidine administration; (2) to compare CaO 2, CvO 2, CaO 2 CvO 2, and blood lactate concentrations in medetomidine-sedated dogs breathing room air versus 100% oxygen insufflation via face mask; and (3) to assess the effect of atipamezole reversal of medetomidine on these variables in dogs. MATERIALS AND METHODS This experiment was approved by the Oklahoma State University Animal Care and Use Committee and conducted at Oklahoma State University. Seven 2-year-old, mixed-breed hound-type dogs (five females and two males) 52
3 J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue were used in this crossover study. Mean (±SD) body weight was 21.2 (±1.8) kg. The dogs were randomly assigned to two treatment groups, breathing either room air (M) or 100% oxygen (MO 2 ) insufflated via face mask (oxygen flow rate: 3 L/min) while under sedation with medetomidine (Domitor; Pfizer Animal Health). All dogs received medetomidine (40 µg/kg IV) via a preplaced venous catheter (BD- Angiocath; The Medical Supply Company, Bethpage, NY). Each dog received both treatments in random order, with a 7-day interval between treatments. While breathing room air before drug administration, an arterial catheter was inserted into the dorsal pedal artery of all dogs for blood pressure measurement and blood gas sampling and an IV catheter was inserted into a cephalic vein for blood sampling and drug administration. All dogs were connected to an electrocardiograph before any drug was administered, and a lead-ii electrocardiogram (ECG) and while the animals were breathing room air, dogs were injected with medetomidine (40 µg/kg IV) and then randomly assigned to one of the two treatment groups described above. Atipamezole (200 µg/kg IV) was administered immediately after the 30-minute data were obtained. Arterial and venous blood samples were collected 3 minutes later (i.e., 33 minutes after medetomidine administration). The color of the mucous membranes and tongue was recorded as pink, cyanotic, or pale at each time point during sedation. Blood samples for lactate concentration and a body temperature corrected blood gas analysis (i-stat blood gas analyzer, Heska, Ft. Collins, CO) were obtained immediately after the cardiorespiratory parameters at time zero, 5, 10, 20, 30, and 33 minutes. Body temperature was monitored using a rectal temperature probe and maintained between 37 C and 39 C using a water-heating blanket, towels, and an insulated table. Packed After medetomidine administration, PaO 2 did not change significantly over time in dogs breathing room air. (Datascope-Passport 2; Paramus, NJ) was used to monitor for arrhythmias throughout the experiment. A direct blood pressure transducer (zero reference point set at the level of the right heart) and monitor were used to constantly monitor systolic, diastolic, and mean arterial blood pressures; values were recorded at baseline (time 0) and 2, 5, 10, 15, 20, 25, 30, and 33 minutes after medetomidine administration. Baseline heart rate (HR) and respiratory rate (RR) were measured via direct arterial wave form and chest excursion, respectively. Medetomidine was given immediately after baseline measurements were obtained. After baseline measurements were recorded cell volume (PCV) was determined for each arterial and venous sample. Hemoglobin concentration (Hb) was determined by dividing the PCV by 3 11 and referenced to the Hb value obtained by the blood gas analyzer. CaO 2, CvO 2, and peripheral oxygen extraction ratio were calculated using the following equations 8,9 : CaO 2 = (1.36 Hb SaO 2 ) + ( PaO 2 ) CvO 2 = (1.36 Hb SvO 2 ) + ( PvO 2 ) Oxygen extraction ratio = (CaO 2 CvO 2 / CaO 2 ) 100% The cephalic venous blood was used to measure venous oxygen content to examine the peripheral venous tissue oxygenation and periph- 53
4 Veterinary Therapeutics Vol. 8, No. 1, Spring 2007 PaO 2 (mm Hg) Mean PaO 2 Increased Significantly after Oxygen Insufflation Figure 1. Partial pressure of arterial oxygen (PaO 2 ) in medetomidinesedated (40 µg/kg IV) dogs breathing room air (M) or with 100% oxygen insufflation via face mask (MO 2 ). Time 0 was just before medetomidine administration; time 33 was 3 minutes after atipamezole () administration (200 µg/kg IV). Asterisks indicate a significant difference within the group. eral venous oxygen extraction ratio. The cephalic vein was chosen for ease of access and to examine the peripheral venous oxygenation from a commonly cannulated vessel. Statistical Analysis Analysis of variance was used to assess treatment differences (PROC MIXED in SAS, Version 8.2; SAS Institute, Cary, NC). When a significant difference (P.05) was detected between treatment groups, a protected Fisher s least significant difference test was used for comparison. All results are reported as mean ± SD. RESULTS There was no significant difference in PaO 2 between the two groups while breathing room air at time zero (Figure 1). After MO 2 M medetomidine administration, PaO 2 did not change significantly over time in dogs breathing room air (Figure 1). One dog breathing room air had a hypoxemic episode (PaO 2 of 59 mm Hg) 10 minutes after medetomidine injection. All other dogs had PaO 2 values between 69 and 93 mm Hg. Following 100% oxygen insufflation, the mean PaO 2 increased significantly (P <.0001) and ranged from 151 to 477 mm Hg during the 30 minutes of sedation (Figure 1). There was no significant difference in the PvO 2 values (range: 30 to 53 mm Hg) over time within or between treatment groups (Figure 2). SaO 2 in the M group (measured by blood gas analyzer) was between 92% and 98%, except in the dog with the PaO 2 of 59 mm Hg, which had an SaO 2 of 89%. SaO 2 was 100% in the MO 2 group during the 30 minutes of sedation. In contrast, SvO 2 in both treatment groups decreased significantly after medetomidine administration (from 80.1% [±4.72%] to 64.3% [±6.15%] in the M group and from 82.3% [±4.1%] to 69.2% [±2.5%] in the MO 2 group). These values remained lower than baseline values until atipamezole administration (Figure 3). 54
5 J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue Mucous membrane color was pale in most of the dogs in the M group. At 5 and 10 minutes, three of the seven dogs had a cyanotic tongue. The color became pinker after 10 minutes. None of the dogs receiving oxygen developed cyanosis. Throughout the 30-minute period, CaO 2 was significantly higher in the dogs receiving 100% insufflation compared with the dogs breathing room air (Figure 4). Following the start of 100% oxygen insufflation via face mask, CaO 2 increased significantly from baseline. In contrast, CaO 2 decreased significantly after medetomidine administration in the dogs breathing room air (Figure 4). The CvO 2 decreased significantly from baseline after medetomidine administration in both treatment groups until atipamezole administration (Figure 4). CvO 2 was not significantly different between treatment groups. Both arterial and venous blood lactate concentrations were within the normal reference range (0.6 to 2.9 mmol/dl) for both treatment groups (Figure 5). Neither arterial nor venous blood lactate concentrations changed significantly from baseline following medetomidine administration in either treatment group. However, the blood lactate concentration at 20 minutes was significantly higher (P <.018) in venous blood than in arterial blood in the MO 2 group (Figure 5). Systolic blood pressure did not PvO 2 (mm Hg) Oxygen Saturation (%) Figure 2. Partial pressure of venous oxygen (PvO 2 ) in medetomidine-sedated (40 µg/kg IV) dogs breathing room air (M) or with 100% oxygen insufflation via face mask (MO 2 ). Time 0 was just before medetomidine administration; time 33 was 3 minutes after atipamezole () administration (200 µg/kg IV) No Significant Differences Were Seen in PvO 2 MO 2 M SvO 2 But Not SaO 2 Decreased Significantly after Medetomide Administration SaO 2 in MO 2 SvO 2 in MO 2 SaO 2 in M SvO 2 in M Figure 3. Oxygen saturation in arterial (SaO 2 ) and venous (SvO 2 ) blood of medetomidine-sedated (40 µg/kg IV) dogs breathing room air (M) or with 100% oxygen insufflation via face mask (MO 2 ). Time 0 was just before medetomidine administration; time 33 was 3 minutes after atipamezole () administration (200 µg/kg IV). Asterisks indicate a significant difference within the group. 55
6 Veterinary Therapeutics Vol. 8, No. 1, Spring 2007 Oxygen Content (ml/dl) CaO 2 Was Significantly Higher in Oxygenated Dogs increase significantly from baseline values following medetomidine administration. However, diastolic blood pressure significantly increased from the mean baseline values in both treatment groups after medetomidine administration (Figure 6). Heart rate decreased significantly from the mean baseline values following medetomidine administration in both treatment groups (M: [±10.6] to 38.7 [±2.5] bpm; MO 2 : [±12.3] to 51.5 [±8.3] bpm). Respiratory rate did not change significantly from baseline. There was no significant difference between the two treatment groups in heart and respiratory rates at any time point. Atipamezole administration resulted in an increase in PaO 2 in dogs breathing room air (72.57 [±6.75] to [±7.79] mm Hg); however, the increase was not statistically significant. In contrast, a significant (P <.001) reduction in PaO 2 was observed in dogs given CaO 2 in MO 2 CvO 2 in MO 2 CaO 2 in M CvO 2 in M Figure 4. Oxygen content of arterial (CaO 2 ) and venous (CvO 2 ) blood of medetomidine-sedated (40 µg/kg IV) dogs breathing room air (M) or with 100% oxygen insufflation via face mask (MO 2 ). Time 0 was just before medetomidine administration; time 33 was 3 minutes after atipamezole () administration (200 µg/kg IV). Asterisks indicate a significant difference within the group. Daggers indicate a significant difference between groups. 100% oxygen (from [±17.53] to [±46.42] mm Hg; Figure 1). CaO 2 did not change significantly following atipamezole administration in either treatment group (M: [±0.1] to [±0.09] ml/dl; MO 2 : [±0.05] to [±0.15] ml/dl). PvO 2 increased following atipamezole treatment (M: [±5.39] to 65.5 [±5.64] mm Hg; MO 2 : [±4.62] to 84.0 [±13.86] mm Hg), but these increases were not statistically significant. In contrast, SvO 2 increased significantly following atipamezole administration in the room air group (from 75.4% [±3.5%] to 89.7% [±3.4%]) and in the 100% insufflation group (from 79.7% [±5.1%] to 92.5% [±2.8%]). An increase was also observed in CvO 2 (M: from 17.5 [±0.12] to [±0.1] ml/dl; MO 2 : from [±0.9] to [±0.09] ml/dl). Systolic blood pressure did not change significantly immediately before or after atipamezole administration. Diastolic blood pressure, however, was reduced significantly following atipamezole administration. Mucous membrane color went from pale or pale pink to bright pink in all animals breathing room air. Heart rate increased significantly following atipamezole administration; respiratory rate did not change significantly after administration of atipamezole. Tissue extraction ratio increased significantly at 5 and 10 minutes after medetomidine administration in the group breathing room air. The same was true throughout the sedation period in the group receiving 100% oxygen insufflation. The administration of atipamezole resulted in a significant decrease in tissue oxy- 56
7 J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue gen extraction ratio in both treatment groups. This reduction was far lower than the recorded baseline value for each group (Figure 7). All dogs recovered without complications. DISCUSSION Administration of medetomidine at a dose of 40 µg/kg IV provides sufficient sedation and analgesia for a variety of clinical Lactate Concentration (mmol/dl) procedures Side effects of medetomidine use include hypertension, bradycardia, hypotension, and reduction in cardiac output. 2 This dose (40 µg/kg) was chosen to examine the effects of a higher dose of medetomidine on peripheral tissue oxygenation and blood lactate concentration. The results of this study demonstrate that providing 100% oxygen insufflation during medetomidine sedation prevented the decrease in CaO 2 seen in dogs breathing ambient air. The increase in CaO 2 observed with 100% oxygen insufflation correlated with a significant increase in PaO 2. Although the increase of SaO 2 from baseline following 100% oxygen insufflation was not statistically significant, this increase could be physiologically significant and a contributor to the significant increase in CaO 2. The majority of oxygen in blood is carried by hemoglobin, and even a small increase in SaO 2 correlates with an increase in CaO 2 more so than does an increase in PaO 2. An increase in CaO 2 can provide a wider safety margin to dogs sedated with medetomidine by providing a larger amount of available oxygen to tissues for oxygen extraction. The potential beneficial effect of 100% oxygen insufflation during medetomidine sedation is made evident by the significantly Lactate Concentration Remained within the Normal Reference Range in Both Groups Arterial Concentration in MO 2 Arterial Concentration in M Figure 5. Lactate concentration in arterial and venous blood of medetomidine-sedated (40 µg/kg IV) dogs breathing room air (M) or with 100% oxygen insufflation via face mask (MO 2 ). Time 0 was just before medetomidine administration; time 33 was 3 minutes after atipamezole () administration (200 µg/kg IV). Asterisk indicates a significant difference between the groups. Venous Concentration in MO 2 Venous Concentration in M higher tissue oxygen extraction ratios observed throughout the sedation period (Figure 7). This observation was also accompanied by lower arterial blood lactate concentrations in the sedated dogs receiving oxygen insufflation versus those breathing room air. It has been suggested that the bluish tongue and mucous membrane color of medetomidine-sedated dogs is due to peripheral vasoconstriction resulting in low blood flow through peripheral capillary beds and decreased venous saturation. 1,3,4 In this study, cyanosis was observed only in the dogs breathing room air and was not evident in dogs insufflated with 100% oxygen via face mask. Evidently, to observe medetomidine-induced cyanosis in the dogs in this study, a significant reduction in CaO 2 was necessary in addition to decreased venous saturation and vasoconstriction. Furthermore, 57
8 Veterinary Therapeutics Vol. 8, No. 1, Spring 2007 Blood Pressure (mm Hg) Diastolic But Not Systolic Blood Pressure Increased Significantly after Medetomine Administration SBP in MO 2 SBP in M DBP in MO 2 DBP in M Figure 6. Systolic (SBP) and diastolic (DBP) blood pressure of medetomidine-sedated (40 µg/kg IV) dogs breathing room air (M) or with 100% oxygen insufflation via face mask (MO 2 ). Time 0 was just before medetomidine administration; time 33 was 3 minutes after atipamezole () administration (200 µg/kg IV). Asterisks indicate a significant difference within the group. cyanosis occurred only when CaO 2 was lowest (5 to 10 minutes after medetomidine administration) during the 30-minute sedation period. Providing 100% oxygen insufflation significantly increased the PaO 2 value and resulted in higher CaO 2, evidently preventing cyanosis. This occurred despite a significant reduction in venous saturation (as evident by significant decreases in SvO 2 and CvO 2 ) and medetomidineinduced vasoconstriction. Although medetomidine administration in healthy dogs breathing room air did not cause a statistically significant decrease in either PaO 2 or SaO 2, together their reduction resulted in a significant reduction in CaO 2 for at least 10 minutes. This CaO 2 reduction resulted in reduced oxygen availability to the peripheral tissues, evidenced by a significant increase in arterial blood lactate concentrations. This could be a critical disadvantage in compromised clinical patients. Based on the results of this study, we suggest the administration of 100% oxygen to help prevent a further decrease in CaO 2 when cyanosis occurs following medetomidine administration. In the current study, the oxygen extraction ratio increased significantly following medetomidine administration in both treatment groups and coincided with a significant increase in blood pressure, especially diastolic blood pressure. This observation supports the hypothesis that medetomidine-induced peripheral vasoconstriction results in a lower blood flow through peripheral capillary beds, leading to decreased venous saturation. 1,3,4 The continued increase in oxygen extraction ratio in the group receiving oxygen versus the group breathing room air throughout the sedation period (30 minutes) is intriguing. We hypothesize the larger oxygen extraction ratio simply reflects the increase in PaO 2 and SaO 2 and thus CaO 2 associated with 100% oxygen insufflation, making arterial oxygen supply more readily accessible for tissue extraction. The increase in oxygen availability enables tissues to extract more oxygen to meet metabolic oxygen demand, hence the larger extraction ratio. Blood lactate has been used to monitor tissue perfusion and tissue oxygenation. Lactate concentration is most commonly elevated with tissue hypoperfusion and hypoxia. 11 Normal blood lactate concentration in dogs is suggested to be less than 2.5 mmol/dl. Values between 5 and 7 mmol/dl are considered moderately elevated, and values above 7 mmol/dl are considered severely elevated. 11 In this study, all lactate concentrations obtained from the cephalic vein and the dorsal metatarsal artery were less than 2.5 mmol/dl at any time, indicating that the medetomidine- 58
9 J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue sedated dogs were not hyperlactatemic, regardless of treatment group. This is in agreement with previous work measuring lactate levels in dogs sedated with a lower dose of medetomidine. 16 Following medetomidine administration, no significant increases in blood lactate were observed in either arterial or venous blood in both treatment groups.. All blood lactate concentrations were within physiologic reference ranges, which potentially indicate that there was no tissue hypoxia induced hyperlactatemia and may partially explain why clinically healthy dogs sedated with medetomidine and breathing room air recover without serious consequences despite the appearance of cyanosis. The duration of medetomidine sedation in this study was 30 minutes; it is unknown what effect a longer period of sedation may have on subsequent anaerobic metabolism and blood lactate concentration. Atipamezole is a specific α 2 -adrenergic antagonist and is frequently used to reverse medetomidine. As expected, atipamezole reversal induced vasodilation and significantly reduced diastolic blood pressure. The vasodilation following atipamezole administration allows more oxygen to become available for tissue extraction than can be used. This was evident in the present study by a significantly lower oxygen extraction ratio and a much higher CvO 2 and SvO 2, which explains why there is such a dramatic change to a bright pink mucous membrane color immediately following atipamezole reversal of medetomidine. Furthermore, atipamezole administration significantly reduces the venous blood lactate concentration evident during medetomidine sedation, indicating a reduction in oxygen deprivation. PvO 2 (mm Hg) Atipamezole Administration Significantly Decreased Tissue Oxygen Extraction Ratio in Both Group MO 2 M Figure 7. Oxygen extraction ratio in medetomidine-sedated (40 µg/kg IV) dogs breathing room air (M) or with 100% oxygen insufflation via face mask (MO 2 ). Time 0 was just before medetomidine administration; time 33 was 3 minutes after atipamezole () administration (200 µg/kg, IV). Asterisks indicate a significant difference within the group. Daggers indicate a significant difference between groups. CONCLUSION Based on the results of this study, we conclude that (1) medetomidine administration resulted in peripheral vasoconstriction and increased venous desaturation via an increase in peripheral tissue oxygen extraction; (2) providing 100% oxygen via face mask prevented blood desaturation by increasing CaO 2 but did not influence vasoconstriction nor the increased oxygen extraction ratio in the peripheral tissue; and (3) atipamezole reversed medetomidine-induced vasoconstriction and increased oxygen supply to peripheral tissues as indicated by a lower tissue oxygen extraction ratio. We conclude that the provision of 100% oxygen via insufflation with a face mask benefits tissue oxygenation in dogs sedated with medetomidine. ACKNOWLEDGMENT This study was funded by a research grant from Pfizer Animal Health, New York, NY. 59
10 Veterinary Therapeutics Vol. 8, No. 1, Spring 2007 REFERENCES 1. Sinclair MD: A review of the physiological effects of α2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J 44: , Kuo WC, Keegan RD: Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidinebutorphanol in dogs. Am J Vet Res 65(7): , England GCW, Clarke KW: The effect of route of administration upon the efficacy of medetomidine. J Assoc Vet Anaesth 16:32 34, Clarke KW, England GCW: Medetomidine, a new sedative-analgesia for use in the dog and its reversal with atipamezole. J Small Anim Pract 30: , Vaha-Vahe AT: Clinical evaluation of medetomidine, a novel sedative and analgesic drug for dogs and cats. Acta Vet Scand 30: , Martin L: PaO2, SaO2 and oxygen content, in Martin L (ed): All You Really Need to Know to Interpret Arterial Blood Gases. Philadelphia, Lippincott Williams & Wilkins, 1999, pp Ko JC, Bailey JE, Pablo LS, Heaton-Jones TG: Comparison of sedative and cardiorespiratory effects of medetomidine and medetomidine-butorphanol combination in dogs. Am J Vet Res 57: , Ko JC, Fox SM, Mandsager RE: Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. JAVMA 216: , Oeseburg B, Rolfe P, Siggaard Andersen O, et al: Definition and measurement of quantities pertaining to oxygen in blood, in Vasupel V (ed): Oxygen Transport to Tissue XV. New York, Plenum Press, 1994, pp Helfaer MA, Nichols DG, Rogers MC: Developmental physiology of the respiratory system, in Rogers MC (ed): Textbook of Pediatric Intensive Care. Baltimore, Williams & Wilkins, 1996, pp Karagiannis MH, Reniker AN, Keral ME, Mann FA: Lactate measurement as an indicator of perfusion. Compend Contin Educ Prac Vet 28: , Vainio O, Vaha-Vahe T, Palmu L: Sedative and analgesic effect of medetomidine in dogs. J Vet Pharmacol Ther 12: , Simon F, Romvary A, Mora S: Clinical investigations of medetomidine in dogs. Acta Vet Scand 85: , Vaha-Vahe T: The clinical efficacy of medetomidine. Acta Vet Scand 85: , Nilsfors L, Garmer L, Adolfsson A: Sedative and analgesic effects of medetomidine in dogs An open clinical study. Acta Vet Scand Suppl 85: , Pettifer GR, Dyson DH: Comparison of medetomidine and fentanyl-droperidol in dogs: Sedation, analgesia, arterial blood gases and lactate levels. Can J Vet Res 57:99 105,
Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine Zolazepam Butorphanol and Tiletamine Zolazepam Butorphanol Medetomidine in Dogs*
J. C. H. Ko, M. Payton, A. B. Weil, T. Kitao, and T. Haydon Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine Zolazepam Butorphanol and Tiletamine Zolazepam Butorphanol Medetomidine
More informationDexmedetomidine and its Injectable Anesthetic-Pain Management Combinations
Back to Anesthesia/Pain Management Back to Table of Contents Front Page : Library : ACVC 2009 : Anesthesia/Pain Management : Dexmedetomidine Dexmedetomidine and its Injectable Anesthetic-Pain Management
More informationReversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole
Exp. Anim. 53(5), 423 428, 2004 Reversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole Min Su KIM 1), Seong Mok JEONG 1), Jae Hak PARK 2), Tchi Chou NAM 1) and Kang Moon SEO
More informationb Department of Statistics
A Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine Zolazepam Butorphanol and Tiletamine Zolazepam Butorphanol Medetomidine in Cats Jeff C. H. Ko, DVM, MS, DACVA a Lisa A. Abbo, DVM
More informationThe cardiovascular and respiratory effects of medetomidine and thiopentone anaesthesia in dogs breathing at an altitude of 1486 m
Article Artikel The cardiovascular and respiratory effects of medetomidine and thiopentone anaesthesia in dogs breathing at an altitude of 1486 m K E Joubert a and R Lobetti b ABSTRACT The purpose of this
More informationAlfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS
Alfaxan (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. NADA 141-342, Approved by FDA ALFAXAN (Schedule: C-IV) (alfaxalone 10 mg/ml) Intravenous injectable anesthetic
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, ES,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Medeson 1 mg/ml solution for injection for dogs and cats [AT, CY, CZ, DE, EL, ES, HR, IT, LT, LV, PL, PT, RO, SI, SK] Medeson,
More information1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
PACKAGE LEAFLET FOR: Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, PT, UK] Reanest 1 mg/ml solution for injection for dogs and cats
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Domitor 1 solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Medetomidine hydrochloride (equivalent
More informationPremedication with alpha-2 agonists procedures for monitoring anaesthetic
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Premedication with alpha-2 agonists procedures for monitoring anaesthetic Author : Lisa Angell, Chris Seymour Categories :
More informationPreanesthesia in dogs Dog Weight. Sedation/analgesia in dogs Dog Weight. Sedation/analgesia and preanesthesia in cats
Package Insert NADA 141-267, Approved by FDA. (dexmedetomidine hydrochloride) Sterile Injectable Solution 0.5 mg/ml Intramuscular and Intravenous use in Dogs Intramuscular use in Cats Sedative, Analgesic,
More informationThis SOP presents commonly used anesthetic regimes in rabbits.
Comparative Medicine SOP #: 103. 01 Page: 1 of 7 Rabbit Anaesthesia The intent of this Standard Operating Procedure (SOP) is to describe commonly used methods to anesthetize rabbits at Comparative Medicine
More informationCanine Dosing Chart DEXDOMITOR
Canine Dosing Chart DEXDOMITOR (dexmedetomidine) -.5 mg/ Preanesthesia in dogs Sedation/analgesia in dogs Canine Weight 5 IM 375 IM 375 IV 5 IM lb kg kg kg kg kg 4.4 7 3.4.4 8.. 8.. 4.5 7. 3. 4 8.3.5 5.5
More informationJournal of Zoo and Wildlife Medicine 33(2): , 2002 Copyright 2002 by American Association of Zoo Veterinarians
Journal of Zoo and Wildlife Medicine 33(2): 1, 02 Copyright 02 by American Association of Zoo Veterinarians CARDIORESPIRATORY EFFECTS OF MEDETOMIDINE BUTORPHANOL, MEDETOMIDINE BUTORPHANOL DIAZEPAM, AND
More informationPain Management in Racing Greyhounds
Pain Management in Racing Greyhounds Pain Pain is a syndrome consisting of multiple organ system responses, and if left untreated will contribute to patient morbidity and mortality. Greyhounds incur a
More informationDexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History
Dexmedetomidine Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai Dexmedetomidine is the most recently released IV anesthetic. It is a highly selective α 2 -adrenergic agonist
More informationClinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 / 2007
1 / 2007 Clinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 5 Dexmedetomidine: a new 2-adrenoceptor agonist for modern multimodal anaesthesia in dogs and cats
More informationHemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery
Hemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery Juan F. De la Mora-González *, José A. Robles-Cervantes 2,4, José M. Mora-Martínez 3, Francisco Barba-Alvarez
More informationCardiovascular, respiratory, electrolyte and acid base balance during continuous dexmedetomidine infusion in anesthetized dogs
Veterinary Anaesthesia and Analgesia, 2013, 40, 464 471 doi:10.1111/vaa.12036 RESEARCH PAPER Cardiovascular, respiratory, electrolyte and acid base balance during continuous dexmedetomidine infusion in
More informationAnesthetic regimens for mice, rats and guinea pigs
Comparative Medicine SOP #: 101. 01 Page: 1 of 10 Anesthetic regimens for mice, rats and guinea pigs The intent of the Standard Operating Procedure (SOP) is to describe commonly used methods to anaesthetize
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NOSEDORM 5 mg/ml Solution for injection for dogs and cats [DE, ES, FR, PT] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationShort duration anaesthesia with medetomidine and ketamine in cynomolgus monkeys
Short duration anaesthesia with medetomidine a ketamine in cynomolgus monkeys S. S. Young, A. M. Schilling, S. Skeans & G. Ritacco Department of Allergy, Schering-Plough Research Institute, Kenilworth,
More informationUSE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES
ISSN 1023-1072 Pak. J. Agri., Agril. Engg., Vet. Sci., 2010, 26 (2): 87-99 USE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES 11 A. B. Kalhoro, M. Tariq, A. B. Kachiwal, R. Rind, D. H. Kalhoro
More informationProceedings of the International Congress of the Italian Association of Companion Animal Veterinarians
www.ivis.org Proceedings of the International Congress of the Italian Association of Companion Animal Veterinarians June 8-10, 2012 - Rimini, Italy Next SCIVAC Congress: Mar. 8-10, 2013 Pisa, Italy SCIVAC
More informationAnaesthesia and Analgesia of fish
Anaesthesia and Analgesia of fish Dr Stewart Fielder Port Stephens Fisheries Institute Marine fish production and enhancement Plan of talk Who uses anaesthetics for fish Why anaesthetics are used When
More informationDay 90 Labelling, PL LABELLING AND PACKAGE LEAFLET
LABELLING AND PACKAGE LEAFLET A. LABELLING PARTICULARS TO APPEAR ON THE OUTER PACKAGE : Carton 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs
More informationthe same safe, reliable sedation and analgesia as DEXDOMITOR. specifically made for cats that weigh 7 lb or less.
feline dosing chart DEXDOMITOR 0.1 mg/ml (dexmedetomidine) Sedation/analgesia in cats Feline 40 mcg/kg IM lb kg ml 2 4 1 2 4.1 7 2.1 3 0.5 1.0 For higher weight ranges, use DEXDOMITOR (dexmedetomidine),
More informationtake pain out of the pet s experience.
take pain out of the pet s experience. The analgesic properties of DEXDOMITOR (dexmedetomidine) give dogs and cats respite from mild or moderate pain associated with a procedure. By reducing discomfort,
More informationA New Advancement in Anesthesia. Your clear choice for induction.
A New Advancement in Anesthesia Your clear choice for induction. By Kirby Pasloske When using Alfaxan, patients should be continuously monitored, and facilities for maintenance of a patent airway, artificial
More informationTop 5 Short Procedure Sedation Scenarios
Top 5 Short Procedure Scenarios Khursheed Mama, DVM, DACVAA Colorado State University can be used to facilitate management of aggressive animals, completion of minor procedures (eg, biopsy, laceration
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)
SUMMARY OF PRODUCT CHARACTERISTICS Revised: September 2015 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)
More informationSynopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets
Synopsis Name of the sponsor Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Name of active ingredient Title of the study Study
More informationCardiac MRI Morphology 2004
Cardiac MRI Morphology 2004 1 2 Disclaimers The information in this presentation is strictly educational and is not intended to be used for instruction as to the practice of medicine. Healthcare practitioners
More informationA study to evaluate buprenorphine at 40 lg kg )1 compared to 20 lg kg )1 as a post-operative analgesic in the dog
Veterinary Anaesthesia and Analgesia, 211, 38, 584 593 doi:1.1111/j.1467-2995.211.656.x RESEARCH PAPER A study to evaluate buprenorphine at 4 lg kg )1 compared to 2 lg kg )1 as a post-operative analgesic
More informationA Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital
Original Research A Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital Kamala GR 1, Leela GR 2 1 Assistant Professor, Department of Anaesthesiology,
More informationStudy between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation
Original Research Article Study between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation K. Selvarju 1, Kondreddi Narayana Prasad 2*, Ajay Kumar Reddy Bobba
More informationClinical effects and pharmacokinetic variables of romifidine and the peripheral a 2 -adrenoceptor antagonist MK-467 in horses
Veterinary Anaesthesia and Analgesia, 2016, 43, 599 610 doi:10.1111/vaa.12354 RESEARCH PAPER Clinical effects and pharmacokinetic variables of romifidine and the peripheral a 2 -adrenoceptor antagonist
More informationISMP Canada HYDROmorphone Knowledge Assessment Survey
ISMP Canada HYDROmorphone Knowledge Assessment Survey Knowledge Assessment Questions 1. In an equipotent dose, HYDROmorphone is more potent than morphine. True False Unsure 2. HYDROmorphone can be given
More informationWhat dose of methadone should I use?
What dose of methadone should I use? Professor Derek Flaherty BVMS, DVA, DipECVAA, MRCA, MRCVS RCVS and European Specialist in Veterinary Anaesthesia SPC dose rates for Comfortan dogs: 0.5-1.0 mg/kg SC,
More informationComparison of 3 Total Intravenous Anesthetic Infusion Combinations in Adult Horses
Comparison of 3 Total Intravenous Anesthetic Infusion Combinations in Adult Horses Courtney L. Baetge, DVM Nora S. Matthews, DVM, Dip. ACVA Gwendolyn L. Carroll, DVM, Dip. ACVA Texas A&M University College
More informationA Comparative Evaluation of Intranasal Dexmedetomidine and Intranasal Midazolam for Premedication in Pediatric Surgery
Original Research Article A Comparative Evaluation of Intranasal Dexmedetomidine and Intranasal Midazolam for Premedication in Pediatric Surgery Dr. Shweta Nitturi 1*, Dr. Olvyna D souza 2 1 ICU Junior
More informationT u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods
T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods Abbreviations: General Considerations IV = intravenous SC = subcutaneous
More informationPakistan Veterinary Journal
RESEARCH ARTICLE Pakistan Veterinary Journal ISSN: 5-88 (PRINT), 74-7764 (ONLINE) Accessible at: www.pvj.com.pk A Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine-Zolazepam/Xylazine
More informationComparative efficacy of DRAXXIN or Nuflor for the treatment of undifferentiated bovine respiratory disease in feeder cattle
Treatment Study DRAXXIN vs. Nuflor July 2005 Comparative efficacy of DRAXXIN or Nuflor for the treatment of undifferentiated bovine respiratory disease in feeder cattle Pfizer Animal Health, New York,
More informationDOI /yydb medetomidine a review of clinical applications J. Curr Opin Anaesthesiol
1573 medetomidine a review of clinical applications J. Curr Opin Anaesthesiol 2008 21 4 457-461. 6 DAHMANI S PARIS A JANNIER V et al. Dexmedetom- 2. α 2 idine increases hippocampal phosphorylated extracellular
More informationAnesthesia & analgesia in birds
Anesthesia and analgesia in birds Yvonne R.A. van Zeeland, DVM, PhD, MVR, Dip. ECZM (avian) Division of Zoological Medicine, Utrecht University Anesthesia & analgesia in birds Yvonne van Zeeland DVM, MVR,
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Veterinary Anaesthesia and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2015 Veterinary Anaesthesia and Critical Care Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours
More informationECG CHANGES IN DOGS SEDATED WITH DEXMEDETOMIDINE AND MIDAZOLAM- DEXMEDETOMIDINE COMBINATION
ECG CHNGES IN DOGS SEDTED WITH DEXMEDETOMIDINE ND MIDZOLM- DEXMEDETOMIDINE COMINTION Raja ijaz hmad 1, marpal 2, H. P. ithal 2, P. Kinjavdekar 3, and. M Pawde 3 1 PhD Scholar, 2 Senior Scientist, 3 Principal
More informationComparison of two doses of intranasal dexmedetomidine as premedication in children
Comparison of two doses of intranasal dexmedetomidine as premedication in children V. Pavithra, M. N. Ramani, S. K. Shah Department of Anaesthesia, B. J. Medical College, Civil Hospital, Ahmedabad, Gujarat,
More informationProcedure # IBT IACUC Approval: December 11, 2017
IACUC Procedure: Anesthetics and Analgesics Procedure # IBT-222.04 IACUC Approval: December 11, 2017 Purpose: The purpose is to define the anesthetics and analgesics that may be used in mice and rats.
More informationAssessing antihypertensive adherence with therapeutic drug monitoring Erika SW JONES, Maia LESOSKY, Marc BLOCKMAN, Sandra CASTEL, Eric H DECLOEDT,
Assessing antihypertensive adherence with therapeutic drug monitoring Erika SW JONES, Maia LESOSKY, Marc BLOCKMAN, Sandra CASTEL, Eric H DECLOEDT, Sylva LU SCHWAGER, Edward D STURROCK, Lubbe WIESNER, Brian
More informationCO Oguntoye* & BO Oke
RESEARCH ARTICLE Sokoto Journal of Veterinary Sciences (P-ISSN 1595-093X/ E-ISSN 2315-6201) Oguntoye & Oke /Sokoto Journal of Veterinary Sciences (2014) 12(3): 21-25 http://dx.doi.org/10.4314/sokjvs.v12i3.4
More informationFeline blood transfusions: preliminary considerations
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Feline blood transfusions: preliminary considerations Author : Andrea Harvey Categories : RVNs Date : September 1, 2011 ABSTRACT
More informationEarn a rebate on pioneering brands you trust.
SPRING INTO SPRING PROMOTION Earn a rebate on pioneering brands you trust. For over 20 years and with your help, Zoetis has changed the veterinary world with the shared vision to provide comfort through
More informationSusan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA
Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA Disclosures Study and presentation has no commercial bias or interests No financial relationship with a commercial interest, products,
More informationTransnasal administration of a combination of dexmedetomidine, midazolam and butorphanol produces deep sedation in New Zealand White rabbits
Veterinary Anaesthesia and Analgesia, 2016, 43, 209 214 doi:10.1111/vaa.12278 SHORT COMMUNICATION Transnasal administration of a combination of dexmedetomidine, midazolam and butorphanol produces deep
More informationVol. 24, No. 5 May Animal Care Center of Sonoma County Sonoma, California Marcia L. Aubin, DVM, MS*
Vol. 24, No. 5 May 2002 411 CE Article #5 (1.5 contact hours) Refereed Peer Review Comments? Questions? Email: compendium@medimedia.com Web: VetLearn.com Fax: 800-556-3288 KEY FACTS Achieving adequate
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DEXDOMITOR 0.1 mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Excipients:
More informationGastric Dilatation-Volvulus
Gastric Dilatation-Volvulus The term "ACVS Diplomate" refers to a veterinarian who has been board certified in veterinary surgery. Only veterinarians who have successfully completed the certification requirements
More informationA comparison of three combinations of injectable anesthetics in miniature donkeys
Veterinary Anaesthesia and Analgesia, 2002, 29, 36^42 RESEARCH PAPER A comparison of three combinations of injectable anesthetics in miniature donkeys Nora S Matthews DVM, Dip ACVA, Tex S Taylor DVM, Dip
More informationNon-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Sedadex 0.1 mg/ml solution for injection for dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Dexmedetomidine hydrochloride
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cepedex 0.1 mg/ml solution for injection for dogs and cats. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Xylacare 2% w/v Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Qualitative composition
More informationGastroduodenoscopy is a procedure commonly used. Evaluation of the effects of premedication on gastroduodenoscopy in cats
Evaluation of the effects of premedication on gastroduodenoscopy in cats Alison A. Smith, DVM; Lysa P. Posner, DVM; Richard E. Goldstein, DVM, DACVIM; John W. Ludders, DVM, DACVA; Hollis N. Erb, DVM, PhD;
More informationComparative Evaluation of the Speed of Flea Kill of Imidacloprid and Selamectin on Dogs*
R. Everett, J. Cunningham, R. Arther, D. L. Bledsoe, and N. Mencke Comparative Evaluation of the Speed of Flea Kill of Imidacloprid and Selamectin on Dogs* Ronald Everett, PhD a Jerry Cunningham, MS a
More informationSCIENTIFIC COOPERATIONS MEDICAL WORKSHOPS July, 2015, Istanbul - TURKEY
21-22 July, 2015, Istanbul - TURKEY PROSPECTIVE EVALUATION OF CORRELATION OF DEPTH OF DEXMEDETOMIDINE SEDATION AND CLINICAL EFFECTS FOR RECONSTRUCTIVE SURGERIES UNDER REGIONAL ANAESTHESIA Alma Jaunmuktane
More informationketamine resulted in prolonged hypertension 11. In dogs renal failure has also
Article Artikel Cardiopulmonary effects of medetomidine or midazolam in combination with ketamine or tiletamine/zolazepam for the immobilisation of captive cheetahs (Acinonyx jubatus) G F Stegmann a* and
More informationPeriod of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)
Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency of Bayer's
More informationGuide to Veterinary Surgery If you are like most people, you want to know what you
Guide to Veterinary Surgery If you are like most people, you want to know what you are paying for and why things cost what they do. You will find that veterinary providers are all different, and you may
More informationUse of Dexmedetomidine for Sedation of Children Hospitalized in the Intensive Care Unit
ORIGINAL RESEARCH Use of Dexmedetomidine for Sedation of Children Hospitalized in the Intensive Care Unit Christopher L. Carroll, MD 1 Diane Krieger, MSN, CPNP 1 Margaret Campbell, PharmD 2 Daniel G. Fisher,
More informationSAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY. Aileen Milne PhD, Manager, Safety Pharmacology
SAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY Aileen Milne PhD, Manager, Safety Pharmacology SAFETY PHARMACOLOGY SERVICES OVERVIEW Full Range of S7A and S7B studies herg assay Respiratory function plethysmography(rat/mouse)
More informationCorresponding author: V. Dua, Department of Anaesthesia, BJ Wadia Hospital for Children, Parel, Mumbai, India.
Comparative evaluation of dexmedetomidine as a premedication given intranasally vs orally in children between 1 to 8 years of age undergoing minor surgical procedures V. Dua, P. Sawant, P. Bhadlikar Department
More informationAPPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE
APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE MARK WITH AN X IN THE BOX FOR ONE OF THE FOLLOWING AND TYPE YOUR CURRENT PROTOCOL NUMBER IF NEEDED: X New application Amendment
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Butomidor 10 mg/ml - Solution for injection for horses, dogs and cats SPC_labelling_PIL 22 December 2011 [Version 7.2, 12/2008] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL
More informationCAT AND DOG ANESTHESIA
Document: ACUP104.03 Issue Date: 21 SEP 17; Effective Date: 21 SEP 17 Authorization: Dr. N. Place, IACUC Chair Author: E. Silvela (Revision) CAT AND DOG ANESTHESIA 1. PURPOSE 1.1. The purpose of this Animal
More informationWelcome! 10/26/2015 1
Welcome! Audio for this event is available via ReadyTalk Internet Streaming. No telephone line is required. Computer speakers or headphones are necessary to listen to streaming audio. Limited dial-in lines
More informationN.C. A and T List of Approved Analgesics 1 of 5
1 of 5 Note to user: This list of commonly used analgesics and sedatives is not all-inclusive. The absence of an agent does not necessarily mean it is unacceptable. For any questions, call the Clinical
More informationPOLICY ON ASEPTIC RECOVERY SURGERY ON USDA REGULATED NONRODENT SPECIES Adopted by the University Committee on Animal Resources October 15, 2014
POLICY ON ASEPTIC RECOVERY SURGERY ON USDA REGULATED NONRODENT SPECIES Adopted by the University Committee on Animal Resources October 15, 2014 The U.S.D.A Animal Welfare Act (9 CFR) requires use of aseptic
More informationANESTHESIA, CHEMICAL RESTRAINT AND PAIN MANAGEMENT IN SNAKES (SERPENTES) A REVIEW. Seven Mustafa, Nadya Zlateva
TRADITION AND MODERNITY IN VETERINARY MEDICINE, 2018, vol. 3, No 1(4): 37 44 ANESTHESIA, CHEMICAL RESTRAINT AND PAIN MANAGEMENT IN SNAKES (SERPENTES) A REVIEW Seven Mustafa, Nadya Zlateva University of
More informationModule C Veterinary Anaesthesia Small Animal Anaesthesia and Analgesia (C-VA.1)
Module C Veterinary Anaesthesia Small Animal Anaesthesia and Analgesia (C-VA.1) Module Leader - Elizabeth Armitage-Chan MA Vet MB DipACVA MRCVS RCVS Specialist in Veterinary Anaesthesia The aim of the
More informationPropofol vs Dexmedetomidine
Propofol vs Dexmedetomidine A highlight of similarities & differences Lama Nazer, PharmD, BCPS Critical Care Clinical Pharmacy Specialist King Hussein Cancer Center Outline Highlight similarities and differences
More informationDexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery?
Cardiac Intensive Care Dexmedetomidine use in a pediatric cardiac intensive care unit: Can we use it in infants after cardiac surgery? Constantinos Chrysostomou, MD; Joan Sanchez De Toledo, MD; Tracy Avolio,
More informationP-ISSN: ; E-ISSN: Journal of Veterinary.
Research Article P-ISSN: 2304-3075; E-ISSN: 2305-4360 International Journal of Veterinary Science www.ijvets.com; editor@ijvets.com Effects of Ketamine-Medetomidine and Ketamine-Medetomidine-Morphine Anaesthesia
More informationA Comparison of the Incidence of Apnoea Following Induction of Anaesthesia with Propofol or Alfaxalone in Dogs
A Comparison of the Incidence of Apnoea Following Induction of Anaesthesia with Propofol or Alfaxalone in Dogs Sarah Elizabeth Bigby ORCID ID: orcid.org/0000-0003-2814-0569 Student ID: 642933 Submitted
More informationHaemodynamic and anaesthetic advantages of dexmedetomidine
Haemodynamic and anaesthetic advantages of dexmedetomidine Abstract Rao SH, Assistant Professor Sudhakar B, Associate Professor Subramanyam PK, Professor Department of Anaesthesia and Critical Care, Dr
More informationEXOTIC SMALL MAMMAL ANESTHETIC TECHNIQUES
EXOTIC SMALL MAMMAL ANESTHETIC TECHNIQUES Jody Nugent-Deal, RVT, VTS (Anesthesia) and (Clinical Practice Exotic Companion Animal) Veterinary Medical Teaching Hospital University of California, Davis, CA
More informationPharmacological Restraint and Reversal using Medetomidine and Atipamezole and Effects on Some Haematological Traits in Goats
VETERINARY CLINICAL SCIENCE Journal homepage: www.jakraya.com/journal/vcs ORIGINAL ARTICLE Pharmacological Restraint and Reversal using Medetomidine and Atipamezole and Effects on Some Onifade K.I. Department
More informationAustralian and New Zealand College of Veterinary Scientists. Fellowship Examination. Veterinary Emergency Medicine and Critical Care Paper 1
Australian and New Zealand College of Veterinary Scientists Fellowship Examination June 2017 Veterinary Emergency Medicine and Critical Care Paper 1 Perusal time: Twenty (20) minutes Time allowed: Four
More informationAvian & Exotic Euthanasia
Avian & Exotic Euthanasia Krista A Keller, DVM, Dipl ACZM Thrive Veterinary Hospital Euthanasia Resource Goals Discuss species specific protocols Exotic companion mammals (and pigs!) Parrots (and other
More informationBehavioral responses following eight anesthetic induction protocols in horses
Veterinary Anaesthesia and Analgesia, 2002, 29, 207^211 RESEARCH PAPER Behavioral responses following eight anesthetic induction protocols in horses Ann E Wagner DVM, MS, Diplomate ACVP, ACVA, Khursheed
More informationPerioperative Pain Management in Veterinary Patients
Perioperative Pain Management in Veterinary Patients Doris H. Dyson, DVM, DVSc KEYWORDS Analgesia Surgical pain Dog Cat As veterinarians in the twenty-first century, we have an ethical responsibility to
More informationPreliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit
Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit R. M. Venn, 1 C. J. Bradshaw, 1 R. Spencer, 2 D. Brealey, 3 E. Caudwell, 3 C. Naughton,
More informationNorthwest A&F University, College of Veterinary Medicine, Yangling, China 3
ACTA VET. BRNO 2013, 82: 219 223; doi:10.2754/avb201382020219 Effects of tramadol with tiletamine/zolazepam-xylazine as anaesthesia in cats Lin Li 1a, Jing Dong 1a, Dezhang Lu 2, Sheng Jiang 3, Dongqi
More informationSedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats
Veterinary Anaesthesia and Analgesia, 2014, 41, 90 96 doi:10.1111/vaa.12076 RESEARCH PAPER Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular
More informationStanding sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana)
Standing sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana) I. Lüders a,b, B. Tindall c, D. Young d, G. van der Horst a,b, S. Botha e, I. Luther a,b, L. Maree
More informationProceedings of the International Congress of the Italian Association of Companion Animal Veterinarians
www.ivis.org Proceedings of the International Congress of the Italian Association of Companion Animal Veterinarians June 8-10, 2012 - Rimini, Italy Next SCIVAC Congress: Mar. 8-10, 2013 Pisa, Italy SCIVAC
More informationSTANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA
STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA 1. PURPOSE This Standard Operating Procedure (SOP) describes methods for anesthetizing mice. 2. RESPONSIBILITY Principal Investigators (PIs) and their
More informationFinancial'Disclosure 3/22/18. Reducing)Fear,)Stress,)&)Pain)in) Anesthesia)Benefits)Everyone. Reduce&Fear& Pain Stress
Reducing)Fear,)Stress,)&)Pain)in) Anesthesia)Benefits)Everyone Ralph&Harvey,&DVM,&MS,&Diplomate&ACVAA Associate&Professor&of&Anesthesiology University&of&Tennessee& Financial'Disclosure I'have'commercial'relationships'with:'Aratana
More informationAntimicrobial Selection and Therapy for Equine Musculoskeletal Trauma
Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma Lucio Petrizzi DVM DECVS Università degli Studi di Teramo Surgical site infections (SSI) Microbial contamination unavoidable Infection
More information